Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

TPE Compounds Gaining Some Traction In Medical-Grade Manufacturing

By Tekni-Plex, Inc. | January 19, 2018

Medical polymer compounds. (Credit: Colorite, a Tekni-Plex unit)

Colorite Cellene TPE compounds are gaining traction as medical device manufacturers seek alternatives to PVC and silicone.

Colorite, a Tekni-Plex business unit specializing in custom medical-grade compounds, says its Cellene line of thermoplastic elastomer (TPE) compounds can help companies proactively address new regulatory dynamics around the globe.

“We have seen the development pipeline increase three-fold since our North American launch approximately a year ago,” explained Heath Schmid, director of business development, advanced materials, Colorite.  “The material is gaining traction globally in a number of applications — such as drip chambers, IV, and peristaltic pump tubing — looking for alternatives to PVC and silicone.”

Although PVC compounds still garner the majority of market share, TPE alternatives are suited for those desiring non-phthalate containing materials.  

“Many companies are trying to proactively address new regulatory dynamics, both in the United States and in many other global regions,” said Schmid. “Some healthcare systems are already implementing strategic initiatives for phthalate-free patient environments.”

Cellene TPEs are suitable for a variety of uses in medical devices, packaging, and other regulated markets. Cellene compounds are formulated to be silicone, latex, phthalate, halogen, and PVC-free using FDA-compliant raw materials to meet USP Class VI and ISO 10993 standards.

(Source: Tekni-Plex, Inc.)

Related Articles Read More >

Diverse factory workers in yellow PPE suits checking production data with clipboard in modern industrial facility, Quality control inspector wearing masks and hairnets working in food or pharma plant
How on-site GMP training drives competitive advantage in pharmaceutical manufacturing
Schott Pharma $60M vial production investment (1)
Schott Pharma invests $60M to expand vial production in Pennsylvania
Tank equipment. Pharmaceutical and chemical industry. Manufacture on plant
Meeting regulatory and quality standards with advanced water purification in biopharma
Niowave Logo
Niowave breaks ground on $75M isotope production facility
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE